Non-small cell lung cancer presenting as "psoas muscle syndrome": a case report

Submitted: November 28, 2018
Accepted: February 5, 2019
Published: April 5, 2019
Abstract Views: 1641
PDF: 1029
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Lung cancer is the leading cause of cancer-related death worldwide and majority of patients are diagnosed in advanced/metastatic disease stage. Sites of distant metastases mainly include contralateral lung, lymph nodes, brain, bones, adrenal glands and liver; skeletal muscles metastases (SMMs) are less common. Psoas muscle and diaphragm metastases are mainly found during autopsy, as their involvement commonly is asymptomatic. We report a case of a 60-year-old female, suffering from non-small cell lung cancer (NSCLC), with refractory lower back pain, as expression of malignant psoas syndrome (MPS). MPS is a rare and difficult-to-treat cancer-pain syndrome, unresponsive to majority of analgesic therapy, related to psoas muscle metastasis; it is usually caused by different tumors such as uterus, ovary, bladder, prostate, colon-rectum, lymphoma, melanoma and sarcoma and represents an uncommon finding in NSCLC patients. 

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Mollica, Mariano, Rosalba Maffucci, Sabrina Lavoretano, Gaetano Rea, Francesco Saverio Cerqua, Luigi Aronne, Andrea Bianco, and Fabio Perrotta. 2019. “Non-Small Cell Lung Cancer Presenting As ‘psoas Muscle syndrome’: A Case Report”. Monaldi Archives for Chest Disease 89 (1). https://doi.org/10.4081/monaldi.2019.1012.

Similar Articles

<< < 10 11 12 13 14 15 16 17 18 19 > >> 

You may also start an advanced similarity search for this article.